Global (North America, Europe and Asia-Pacific, South America, Middle East and Africa) Intravenous Immunoglobulin (IVIg) Market 2018 Forecast to 2023

Publisher Name :
Date: 17-May-2018
No. of pages: 107

"Intravenous Immunoglobulin, also called gamma globulin or antibodies, is a highly purified blood product preparation that is derived from large pools of plasma donors. Plasma from approximately 1,000 to 10,000 persons is present in each unit or "lot" of Intravenous Immunoglobulin.

"

Scope of the Report:

This report focuses on the Intravenous Immunoglobulin (IVIg) in Global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

Market Segment by Manufacturers, this report covers

- Baxter

- Grifols

- CSL

- Octapharma

- Biotest

- Kedrion

- Hualan Bio

- CNBG

- Shanghai RAAS

- CBPO

- LFB Group

- BPL

- Sichuan Yuanda Shuyang

Market Segment by Regions, regional analysis covers

- North America (United States, Canada and Mexico)

- Europe (Germany, France, UK, Russia and Italy)

- Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

- South America (Brazil, Argentina, Colombia etc.)

- Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers

- IVIg Liquid

- IVIg Powder

Market Segment by Applications, can be divided into

- Immunodeficiency

- Autoimmune Disease

- Acute Infection

There are 15 Chapters to deeply display the global Intravenous Immunoglobulin (IVIg) market.

Chapter 1, to describe Intravenous Immunoglobulin (IVIg) Introduction, product scope, market overview, market opportunities, market risk, market driving force;

Chapter 2, to analyze the top manufacturers of Intravenous Immunoglobulin (IVIg), with sales, revenue, and price of Intravenous Immunoglobulin (IVIg), in 2016 and 2017;

Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;

Chapter 4, to show the global market by regions, with sales, revenue and market share of Intravenous Immunoglobulin (IVIg), for each region, from 2013 to 2018;

Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;

Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;

Chapter 12, Intravenous Immunoglobulin (IVIg) market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;

Chapter 13, 14 and 15, to describe Intravenous Immunoglobulin (IVIg) sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source

Global (North America, Europe and Asia-Pacific, South America, Middle East and Africa) Intravenous Immunoglobulin (IVIg) Market 2018 Forecast to 2023

Table of Contents

1 Market Overview
1.1 Intravenous Immunoglobulin (IVIg) Introduction
1.2 Market Analysis by Type
1.2.1 IVIg Liquid
1.2.2 IVIg Powder
1.3 Market Analysis by Applications
1.3.1 Immunodeficiency
1.3.2 Autoimmune Disease
1.3.3 Acute Infection
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2013-2023)
1.4.1.2 Canada Market States and Outlook (2013-2023)
1.4.1.3 Mexico Market States and Outlook (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2013-2023)
1.4.2.2 France Market States and Outlook (2013-2023)
1.4.2.3 UK Market States and Outlook (2013-2023)
1.4.2.4 Russia Market States and Outlook (2013-2023)
1.4.2.5 Italy Market States and Outlook (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2013-2023)
1.4.3.2 Japan Market States and Outlook (2013-2023)
1.4.3.3 Korea Market States and Outlook (2013-2023)
1.4.3.4 India Market States and Outlook (2013-2023)
1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2013-2023)
1.4.4.2 Egypt Market States and Outlook (2013-2023)
1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)
1.4.4.4 South Africa Market States and Outlook (2013-2023)
1.4.4.5 Nigeria Market States and Outlook (2013-2023)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Baxter
2.1.1 Business Overview
2.1.2 Intravenous Immunoglobulin (IVIg) Type and Applications
2.1.2.1 Type 1
2.1.2.2 Type 2
2.1.3 Baxter Intravenous Immunoglobulin (IVIg) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2 Grifols
2.2.1 Business Overview
2.2.2 Intravenous Immunoglobulin (IVIg) Type and Applications
2.2.2.1 Type 1
2.2.2.2 Type 2
2.2.3 Grifols Intravenous Immunoglobulin (IVIg) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3 CSL
2.3.1 Business Overview
2.3.2 Intravenous Immunoglobulin (IVIg) Type and Applications
2.3.2.1 Type 1
2.3.2.2 Type 2
2.3.3 CSL Intravenous Immunoglobulin (IVIg) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4 Octapharma
2.4.1 Business Overview
2.4.2 Intravenous Immunoglobulin (IVIg) Type and Applications
2.4.2.1 Type 1
2.4.2.2 Type 2
2.4.3 Octapharma Intravenous Immunoglobulin (IVIg) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.5 Biotest
2.5.1 Business Overview
2.5.2 Intravenous Immunoglobulin (IVIg) Type and Applications
2.5.2.1 Type 1
2.5.2.2 Type 2
2.5.3 Biotest Intravenous Immunoglobulin (IVIg) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.6 Kedrion
2.6.1 Business Overview
2.6.2 Intravenous Immunoglobulin (IVIg) Type and Applications
2.6.2.1 Type 1
2.6.2.2 Type 2
2.6.3 Kedrion Intravenous Immunoglobulin (IVIg) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.7 Hualan Bio
2.7.1 Business Overview
2.7.2 Intravenous Immunoglobulin (IVIg) Type and Applications
2.7.2.1 Type 1
2.7.2.2 Type 2
2.7.3 Hualan Bio Intravenous Immunoglobulin (IVIg) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.8 CNBG
2.8.1 Business Overview
2.8.2 Intravenous Immunoglobulin (IVIg) Type and Applications
2.8.2.1 Type 1
2.8.2.2 Type 2
2.8.3 CNBG Intravenous Immunoglobulin (IVIg) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.9 Shanghai RAAS
2.9.1 Business Overview
2.9.2 Intravenous Immunoglobulin (IVIg) Type and Applications
2.9.2.1 Type 1
2.9.2.2 Type 2
2.9.3 Shanghai RAAS Intravenous Immunoglobulin (IVIg) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.10 CBPO
2.10.1 Business Overview
2.10.2 Intravenous Immunoglobulin (IVIg) Type and Applications
2.10.2.1 Type 1
2.10.2.2 Type 2
2.10.3 CBPO Intravenous Immunoglobulin (IVIg) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.11 LFB Group
2.11.1 Business Overview
2.11.2 Intravenous Immunoglobulin (IVIg) Type and Applications
2.11.2.1 Type 1
2.11.2.2 Type 2
2.11.3 LFB Group Intravenous Immunoglobulin (IVIg) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.12 BPL
2.12.1 Business Overview
2.12.2 Intravenous Immunoglobulin (IVIg) Type and Applications
2.12.2.1 Type 1
2.12.2.2 Type 2
2.12.3 BPL Intravenous Immunoglobulin (IVIg) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.13 Sichuan Yuanda Shuyang
2.13.1 Business Overview
2.13.2 Intravenous Immunoglobulin (IVIg) Type and Applications
2.13.2.1 Type 1
2.13.2.2 Type 2
2.13.3 Sichuan Yuanda Shuyang Intravenous Immunoglobulin (IVIg) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
3 Global Intravenous Immunoglobulin (IVIg) Market Competition, by Manufacturer
3.1 Global Intravenous Immunoglobulin (IVIg) Sales and Market Share by Manufacturer (2016-2017)
3.2 Global Intravenous Immunoglobulin (IVIg) Revenue and Market Share by Manufacturer (2016-2017)
3.3 Global Intravenous Immunoglobulin (IVIg) Price by Manufacturer (2016-2017)
3.4 Market Concentration Rate
3.4.1 Top 3 Intravenous Immunoglobulin (IVIg) Manufacturer Market Share in 2017
3.4.2 Top 5 Intravenous Immunoglobulin (IVIg) Manufacturer Market Share in 2017
3.5 Market Competition Trend
4 Global Intravenous Immunoglobulin (IVIg) Market Analysis by Regions
4.1 Global Intravenous Immunoglobulin (IVIg) Sales, Revenue and Market Share by Regions
4.1.1 Global Intravenous Immunoglobulin (IVIg) Sales by Regions (2013-2018)
4.1.2 Global Intravenous Immunoglobulin (IVIg) Revenue by Regions (2013-2018)
4.2 North America Intravenous Immunoglobulin (IVIg) Sales, Revenue and Growth Rate (2013-2018)
4.3 Europe Intravenous Immunoglobulin (IVIg) Sales, Revenue and Growth Rate (2013-2018)
4.4 Asia-Pacific Intravenous Immunoglobulin (IVIg) Sales, Revenue and Growth Rate (2013-2018)
4.5 South America Intravenous Immunoglobulin (IVIg) Sales, Revenue and Growth Rate (2013-2018)
4.6 Middle East and Africa Intravenous Immunoglobulin (IVIg) Sales, Revenue and Growth Rate (2013-2018)
5 North America Intravenous Immunoglobulin (IVIg) by Countries, Type, Application and Manufacturers
5.1 North America Intravenous Immunoglobulin (IVIg) Sales, Revenue and Market Share by Countries
5.1.1 North America Intravenous Immunoglobulin (IVIg) Sales by Countries (2013-2018)
5.1.2 North America Intravenous Immunoglobulin (IVIg) Revenue by Countries (2013-2018)
5.1.3 United States Intravenous Immunoglobulin (IVIg) Sales and Growth Rate (2013-2018)
5.1.4 Canada Intravenous Immunoglobulin (IVIg) Sales and Growth Rate (2013-2018)
5.1.5 Mexico Intravenous Immunoglobulin (IVIg) Sales and Growth Rate (2013-2018)
5.2 North America Intravenous Immunoglobulin (IVIg) Sales and Revenue (Value) by Manufacturers (2016-2017)
5.2.1 North America Intravenous Immunoglobulin (IVIg) Sales by Manufacturers (2016-2017)
5.2.2 North America Intravenous Immunoglobulin (IVIg) Revenue by Manufacturers (2016-2017)
5.3 North America Intravenous Immunoglobulin (IVIg) Sales, Revenue and Market Share by Type (2013-2018)
5.3.1 North America Intravenous Immunoglobulin (IVIg) Sales and Sales Share by Type (2013-2018)
5.3.2 North America Intravenous Immunoglobulin (IVIg) Revenue and Revenue Share by Type (2013-2018)
5.4 North America Intravenous Immunoglobulin (IVIg) Sales, Revenue and Market Share by Application (2013-2018)
5.4.1 North America Intravenous Immunoglobulin (IVIg) Sales and Sales Share by Application (2013-2018)
5.4.2 North America Intravenous Immunoglobulin (IVIg) Revenue and Revenue Share by Application (2013-2018)
6 Europe Intravenous Immunoglobulin (IVIg) by Countries, Type, Application and Manufacturers
6.1 Europe Intravenous Immunoglobulin (IVIg) Sales, Revenue and Market Share by Countries
6.1.1 Europe Intravenous Immunoglobulin (IVIg) Sales by Countries (2013-2018)
6.1.2 Europe Intravenous Immunoglobulin (IVIg) Revenue by Countries (2013-2018)
6.1.3 Germany Intravenous Immunoglobulin (IVIg) Sales and Growth Rate (2013-2018)
6.1.4 UK Intravenous Immunoglobulin (IVIg) Sales and Growth Rate (2013-2018)
6.1.5 France Intravenous Immunoglobulin (IVIg) Sales and Growth Rate (2013-2018)
6.1.6 Russia Intravenous Immunoglobulin (IVIg) Sales and Growth Rate (2013-2018)
6.1.7 Italy Intravenous Immunoglobulin (IVIg) Sales and Growth Rate (2013-2018)
6.2 Europe Intravenous Immunoglobulin (IVIg) Sales and Revenue (Value) by Manufacturers (2016-2017)
6.2.1 Europe Intravenous Immunoglobulin (IVIg) Sales by Manufacturers (2016-2017)
6.2.2 Europe Intravenous Immunoglobulin (IVIg) Revenue by Manufacturers (2016-2017)
6.3 Europe Intravenous Immunoglobulin (IVIg) Sales, Revenue and Market Share by Type (2013-2018)
6.3.1 Europe Intravenous Immunoglobulin (IVIg) Sales and Sales Share by Type (2013-2018)
6.3.2 Europe Intravenous Immunoglobulin (IVIg) Revenue and Revenue Share by Type (2013-2018)
6.4 Europe Intravenous Immunoglobulin (IVIg) Sales, Revenue and Market Share by Application (2013-2018)
6.4.1 Europe Intravenous Immunoglobulin (IVIg) Sales and Sales Share by Application (2013-2018)
6.4.2 Europe Intravenous Immunoglobulin (IVIg) Revenue and Revenue Share by Application (2013-2018)
7 Asia-Pacific Intravenous Immunoglobulin (IVIg) by Countries, Type, Application and Manufacturers
7.1 Asia-Pacific Intravenous Immunoglobulin (IVIg) Sales, Revenue and Market Share by Countries
7.1.1 Asia-Pacific Intravenous Immunoglobulin (IVIg) Sales by Countries (2013-2018)
7.1.2 Asia-Pacific Intravenous Immunoglobulin (IVIg) Revenue by Countries (2013-2018)
7.1.3 China Intravenous Immunoglobulin (IVIg) Sales and Growth Rate (2013-2018)
7.1.4 Japan Intravenous Immunoglobulin (IVIg) Sales and Growth Rate (2013-2018)
7.1.5 Korea Intravenous Immunoglobulin (IVIg) Sales and Growth Rate (2013-2018)
7.1.6 India Intravenous Immunoglobulin (IVIg) Sales and Growth Rate (2013-2018)
7.1.7 Southeast Asia Intravenous Immunoglobulin (IVIg) Sales and Growth Rate (2013-2018)
7.2 Asia-Pacific Intravenous Immunoglobulin (IVIg) Sales and Revenue (Value) by Manufacturers (2016-2017)
7.2.1 Asia-Pacific Intravenous Immunoglobulin (IVIg) Sales by Manufacturers (2016-2017)
7.2.2 Asia-Pacific Intravenous Immunoglobulin (IVIg) Revenue by Manufacturers (2016-2017)
7.3 Asia-Pacific Intravenous Immunoglobulin (IVIg) Sales, Revenue and Market Share by Type (2013-2018)
7.3.1 Asia-Pacific Intravenous Immunoglobulin (IVIg) Sales and Sales Share by Type (2013-2018)
7.3.2 Asia-Pacific Intravenous Immunoglobulin (IVIg) Revenue and Revenue Share by Type (2013-2018)
7.4 Asia-Pacific Intravenous Immunoglobulin (IVIg) Sales, Revenue and Market Share by Application (2013-2018)
7.4.1 Asia-Pacific Intravenous Immunoglobulin (IVIg) Sales and Sales Share by Application (2013-2018)
7.4.2 Asia-Pacific Intravenous Immunoglobulin (IVIg) Revenue and Revenue Share by Application (2013-2018)
8 South America Intravenous Immunoglobulin (IVIg) by Countries, Type, Application and Manufacturers
8.1 South America Intravenous Immunoglobulin (IVIg) Sales, Revenue and Market Share by Countries
8.1.1 South America Intravenous Immunoglobulin (IVIg) Sales by Countries (2013-2018)
8.1.2 South America Intravenous Immunoglobulin (IVIg) Revenue by Countries (2013-2018)
8.1.3 Brazil Intravenous Immunoglobulin (IVIg) Sales and Growth Rate (2013-2018)
8.1.4 Argentina Intravenous Immunoglobulin (IVIg) Sales and Growth Rate (2013-2018)
8.1.5 Colombia Intravenous Immunoglobulin (IVIg) Sales and Growth Rate (2013-2018)
8.2 South America Intravenous Immunoglobulin (IVIg) Sales and Revenue (Value) by Manufacturers (2016-2017)
8.2.1 South America Intravenous Immunoglobulin (IVIg) Sales by Manufacturers (2016-2017)
8.2.2 South America Intravenous Immunoglobulin (IVIg) Revenue by Manufacturers (2016-2017)
8.3 South America Intravenous Immunoglobulin (IVIg) Sales, Revenue and Market Share by Type (2013-2018)
8.3.1 South America Intravenous Immunoglobulin (IVIg) Sales and Sales Share by Type (2013-2018)
8.3.2 South America Intravenous Immunoglobulin (IVIg) Revenue and Revenue Share by Type (2013-2018)
8.4 South America Intravenous Immunoglobulin (IVIg) Sales, Revenue and Market Share by Application (2013-2018)
8.4.1 South America Intravenous Immunoglobulin (IVIg) Sales and Sales Share by Application (2013-2018)
8.4.2 South America Intravenous Immunoglobulin (IVIg) Revenue and Revenue Share by Application (2013-2018)
9 Middle East and Africa Intravenous Immunoglobulin (IVIg) by Countries, Type, Application and Manufacturers
9.1 Middle East and Africa Intravenous Immunoglobulin (IVIg) Sales, Revenue and Market Share by Countries
9.1.1 Middle East and Africa Intravenous Immunoglobulin (IVIg) Sales by Countries (2013-2018)
9.1.2 Middle East and Africa Intravenous Immunoglobulin (IVIg) Revenue by Countries (2013-2018)
9.1.3 Saudi Arabia Intravenous Immunoglobulin (IVIg) Sales and Growth Rate (2013-2018)
9.1.4 UAE Intravenous Immunoglobulin (IVIg) Sales and Growth Rate (2013-2018)
9.1.5 Egypt Intravenous Immunoglobulin (IVIg) Sales and Growth Rate (2013-2018)
9.1.6 Nigeria Intravenous Immunoglobulin (IVIg) Sales and Growth Rate (2013-2018)
9.1.7 South Africa Intravenous Immunoglobulin (IVIg) Sales and Growth Rate (2013-2018)
9.2 Middle East and Africa Intravenous Immunoglobulin (IVIg) Sales and Revenue (Value) by Manufacturers (2016-2017)
9.2.1 Middle East and Africa Intravenous Immunoglobulin (IVIg) Sales by Manufacturers (2016-2017)
9.2.2 Middle East and Africa Intravenous Immunoglobulin (IVIg) Revenue by Manufacturers (2016-2017)
9.3 Middle East and Africa Intravenous Immunoglobulin (IVIg) Sales, Revenue and Market Share by Type (2013-2018)
9.3.1 Middle East and Africa Intravenous Immunoglobulin (IVIg) Sales and Sales Share by Type (2013-2018)
9.3.1 Middle East and Africa Intravenous Immunoglobulin (IVIg) Revenue and Revenue Share by Type (2013-2018)
9.4 Middle East and Africa Intravenous Immunoglobulin (IVIg) Sales, Revenue and Market Share by Application (2013-2018)
9.4.1 Middle East and Africa Intravenous Immunoglobulin (IVIg) Sales and Sales Share by Application (2013-2018)
9.4.2 Middle East and Africa Intravenous Immunoglobulin (IVIg) Revenue and Revenue Share by Application (2013-2018)
10 Global Intravenous Immunoglobulin (IVIg) Market Segment by Type
10.1 Global Intravenous Immunoglobulin (IVIg) Sales, Revenue and Market Share by Type (2013-2018)
10.1.1 Global Intravenous Immunoglobulin (IVIg) Sales and Market Share by Type (2013-2018)
10.1.2 Global Intravenous Immunoglobulin (IVIg) Revenue and Market Share by Type (2013-2018)
10.2 IVIg Liquid Sales Growth and Price
10.2.1 Global IVIg Liquid Sales Growth (2013-2018)
10.2.2 Global IVIg Liquid Price (2013-2018)
10.3 IVIg Powder Sales Growth and Price
10.3.1 Global IVIg Powder Sales Growth (2013-2018)
10.3.2 Global IVIg Powder Price (2013-2018)
11 Global Intravenous Immunoglobulin (IVIg) Market Segment by Application
11.1 Global Intravenous Immunoglobulin (IVIg) Sales Market Share by Application (2013-2018)
11.2 Immunodeficiency Sales Growth (2013-2018)
11.3 Autoimmune Disease Sales Growth (2013-2018)
11.4 Acute Infection Sales Growth (2013-2018)
12 Intravenous Immunoglobulin (IVIg) Market Forecast (2018-2023)
12.1 Global Intravenous Immunoglobulin (IVIg) Sales, Revenue and Growth Rate (2018-2023)
12.2 Intravenous Immunoglobulin (IVIg) Market Forecast by Regions (2018-2023)
12.2.1 North America Intravenous Immunoglobulin (IVIg) Market Forecast (2018-2023)
12.2.2 Europe Intravenous Immunoglobulin (IVIg) Market Forecast (2018-2023)
12.2.3 Asia-Pacific Intravenous Immunoglobulin (IVIg) Market Forecast (2018-2023)
12.2.4 South America Intravenous Immunoglobulin (IVIg) Market Forecast (2018-2023)
12.2.5 Middle East and Africa Intravenous Immunoglobulin (IVIg) Market Forecast (2018-2023)
12.3 Intravenous Immunoglobulin (IVIg) Market Forecast by Type (2018-2023)
12.3.1 Global Intravenous Immunoglobulin (IVIg) Sales Forecast by Type (2018-2023)
12.3.2 Global Intravenous Immunoglobulin (IVIg) Market Share Forecast by Type (2018-2023)
12.4 Intravenous Immunoglobulin (IVIg) Market Forecast by Application (2018-2023)
12.4.1 Global Intravenous Immunoglobulin (IVIg) Sales Forecast by Application (2018-2023)
12.4.2 Global Intravenous Immunoglobulin (IVIg) Market Share Forecast by Application (2018-2023)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source

List of Tables and Figures

Figure Intravenous Immunoglobulin (IVIg) Picture
Table Product Specifications of Intravenous Immunoglobulin (IVIg)
Figure Global Intravenous Immunoglobulin (IVIg) CAGR (%), Y-o-Y Growth (&) and Market Size, 2013-2023 (USD Million)
Figure Global Intravenous Immunoglobulin (IVIg) CAGR (%), Y-o-Y Growth (&) and Market Size, 2013-2023 (Sales)
Figure Global Sales Market Share of Intravenous Immunoglobulin (IVIg) by Types in 2017
Figure IVIg Liquid Picture
Figure IVIg Powder Picture
Figure Intravenous Immunoglobulin (IVIg) Sales Market Share by Applications in 2017
Figure Immunodeficiency Picture
Figure Autoimmune Disease Picture
Figure Acute Infection Picture
Figure United States Intravenous Immunoglobulin (IVIg) Revenue (Value) and Growth Rate (2013-2023)
Figure Canada Intravenous Immunoglobulin (IVIg) Revenue (Value) and Growth Rate (2013-2023)
Figure Mexico Intravenous Immunoglobulin (IVIg) Revenue (Value) and Growth Rate (2013-2023)
Figure Germany Intravenous Immunoglobulin (IVIg) Revenue (Value) and Growth Rate (2013-2023)
Figure France Intravenous Immunoglobulin (IVIg) Revenue (Value) and Growth Rate (2013-2023)
Figure UK Intravenous Immunoglobulin (IVIg) Revenue (Value) and Growth Rate (2013-2023)
Figure Russia Intravenous Immunoglobulin (IVIg) Revenue (Value) and Growth Rate (2013-2023)
Figure Italy Intravenous Immunoglobulin (IVIg) Revenue (Value) and Growth Rate (2013-2023)
Figure China Intravenous Immunoglobulin (IVIg) Revenue (Value) and Growth Rate (2013-2023)
Figure Japan Intravenous Immunoglobulin (IVIg) Revenue (Value) and Growth Rate (2013-2023)
Figure Korea Intravenous Immunoglobulin (IVIg) Revenue (Value) and Growth Rate (2013-2023)
Figure India Intravenous Immunoglobulin (IVIg) Revenue (Value) and Growth Rate (2013-2023)
Figure Southeast Asia Intravenous Immunoglobulin (IVIg) Revenue (Value) and Growth Rate (2013-2023)
Figure Brazil Intravenous Immunoglobulin (IVIg) Revenue (Value) and Growth Rate (2013-2023)
Figure Egypt Intravenous Immunoglobulin (IVIg) Revenue (Value) and Growth Rate (2013-2023)
Figure Saudi Arabia Intravenous Immunoglobulin (IVIg) Revenue (Value) and Growth Rate (2013-2023)
Figure South Africa Intravenous Immunoglobulin (IVIg) Revenue (Value) and Growth Rate (2013-2023)
Figure Nigeria Intravenous Immunoglobulin (IVIg) Revenue (Value) and Growth Rate (2013-2023)
Table Baxter Basic Information, Manufacturing Base and Competitors
Table Baxter Intravenous Immunoglobulin (IVIg) Type and Applications
Table Baxter Intravenous Immunoglobulin (IVIg) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Grifols Basic Information, Manufacturing Base and Competitors
Table Grifols Intravenous Immunoglobulin (IVIg) Type and Applications
Table Grifols Intravenous Immunoglobulin (IVIg) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table CSL Basic Information, Manufacturing Base and Competitors
Table CSL Intravenous Immunoglobulin (IVIg) Type and Applications
Table CSL Intravenous Immunoglobulin (IVIg) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Octapharma Basic Information, Manufacturing Base and Competitors
Table Octapharma Intravenous Immunoglobulin (IVIg) Type and Applications
Table Octapharma Intravenous Immunoglobulin (IVIg) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Biotest Basic Information, Manufacturing Base and Competitors
Table Biotest Intravenous Immunoglobulin (IVIg) Type and Applications
Table Biotest Intravenous Immunoglobulin (IVIg) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Kedrion Basic Information, Manufacturing Base and Competitors
Table Kedrion Intravenous Immunoglobulin (IVIg) Type and Applications
Table Kedrion Intravenous Immunoglobulin (IVIg) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Hualan Bio Basic Information, Manufacturing Base and Competitors
Table Hualan Bio Intravenous Immunoglobulin (IVIg) Type and Applications
Table Hualan Bio Intravenous Immunoglobulin (IVIg) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table CNBG Basic Information, Manufacturing Base and Competitors
Table CNBG Intravenous Immunoglobulin (IVIg) Type and Applications
Table CNBG Intravenous Immunoglobulin (IVIg) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Shanghai RAAS Basic Information, Manufacturing Base and Competitors
Table Shanghai RAAS Intravenous Immunoglobulin (IVIg) Type and Applications
Table Shanghai RAAS Intravenous Immunoglobulin (IVIg) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table CBPO Basic Information, Manufacturing Base and Competitors
Table CBPO Intravenous Immunoglobulin (IVIg) Type and Applications
Table CBPO Intravenous Immunoglobulin (IVIg) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table LFB Group Basic Information, Manufacturing Base and Competitors
Table LFB Group Intravenous Immunoglobulin (IVIg) Type and Applications
Table LFB Group Intravenous Immunoglobulin (IVIg) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table BPL Basic Information, Manufacturing Base and Competitors
Table BPL Intravenous Immunoglobulin (IVIg) Type and Applications
Table BPL Intravenous Immunoglobulin (IVIg) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Sichuan Yuanda Shuyang Basic Information, Manufacturing Base and Competitors
Table Sichuan Yuanda Shuyang Intravenous Immunoglobulin (IVIg) Type and Applications
Table Sichuan Yuanda Shuyang Intravenous Immunoglobulin (IVIg) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Global Intravenous Immunoglobulin (IVIg) Sales by Manufacturer (2016-2017)
Figure Global Intravenous Immunoglobulin (IVIg) Sales Market Share by Manufacturer in 2016
Figure Global Intravenous Immunoglobulin (IVIg) Sales Market Share by Manufacturer in 2017
Table Global Intravenous Immunoglobulin (IVIg) Revenue by Manufacturer (2016-2017)
Figure Global Intravenous Immunoglobulin (IVIg) Revenue Market Share by Manufacturer in 2016
Figure Global Intravenous Immunoglobulin (IVIg) Revenue Market Share by Manufacturer in 2017
Table Global Intravenous Immunoglobulin (IVIg) Price by Manufacturer (2016-2017)
Figure Top 3 Intravenous Immunoglobulin (IVIg) Manufacturer (Revenue) Market Share in 2017
Figure Top 6 Intravenous Immunoglobulin (IVIg) Manufacturer (Revenue) Market Share in 2017
Figure Global Intravenous Immunoglobulin (IVIg) Sales and Growth Rate (2013-2018)
Figure Global Intravenous Immunoglobulin (IVIg) Revenue and Growth Rate (2013-2018)
Table Global Intravenous Immunoglobulin (IVIg) Sales by Regions (2013-2018)
Table Global Intravenous Immunoglobulin (IVIg) Sales Market Share by Regions (2013-2018)
Table Global Intravenous Immunoglobulin (IVIg) Revenue by Regions (2013-2018)
Figure Global Intravenous Immunoglobulin (IVIg) Revenue Market Share by Regions in 2013
Figure Global Intravenous Immunoglobulin (IVIg) Revenue Market Share by Regions in 2017
Figure North America Intravenous Immunoglobulin (IVIg) Sales and Growth Rate (2013-2018)
Figure North America Intravenous Immunoglobulin (IVIg) Revenue and Growth Rate (2013-2018)
Figure Europe Intravenous Immunoglobulin (IVIg) Sales and Growth Rate (2013-2018)
Figure Europe Intravenous Immunoglobulin (IVIg) Revenue and Growth Rate (2013-2018)
Figure Asia-Pacific Intravenous Immunoglobulin (IVIg) Sales and Growth Rate (2013-2018)
Figure Asia-Pacific Intravenous Immunoglobulin (IVIg) Revenue and Growth Rate (2013-2018)
Figure South America Intravenous Immunoglobulin (IVIg) Sales and Growth Rate (2013-2018)
Figure South America Intravenous Immunoglobulin (IVIg) Revenue and Growth Rate (2013-2018)
Figure Middle East and Africa Intravenous Immunoglobulin (IVIg) Sales and Growth Rate (2013-2018)
Figure Middle East and Africa Intravenous Immunoglobulin (IVIg) Revenue and Growth Rate (2013-2018)
Figure North America Intravenous Immunoglobulin (IVIg) Revenue and Growth Rate (2013-2018)
Table North America Intravenous Immunoglobulin (IVIg) Sales by Countries (2013-2018)
Table North America Intravenous Immunoglobulin (IVIg) Sales Market Share by Countries (2013-2018)
Figure North America Intravenous Immunoglobulin (IVIg) Sales Market Share by Countries in 2013
Figure North America Intravenous Immunoglobulin (IVIg) Sales Market Share by Countries in 2017
Table North America Intravenous Immunoglobulin (IVIg) Revenue by Countries (2013-2018)
Table North America Intravenous Immunoglobulin (IVIg) Revenue Market Share by Countries (2013-2018)
Figure North America Intravenous Immunoglobulin (IVIg) Revenue Market Share by Countries in 2013
Figure North America Intravenous Immunoglobulin (IVIg) Revenue Market Share by Countries in 2017
Figure United States Intravenous Immunoglobulin (IVIg) Sales and Growth Rate (2013-2018)
Figure Canada Intravenous Immunoglobulin (IVIg) Sales and Growth Rate (2013-2018)
Figure Mexico Intravenous Immunoglobulin (IVIg) Sales and Growth Rate (2013-2018)
Table North America Intravenous Immunoglobulin (IVIg) Sales by Manufacturer (2016-2017)
Figure North America Intravenous Immunoglobulin (IVIg) Sales Market Share by Manufacturer in 2016
Figure North America Intravenous Immunoglobulin (IVIg) Sales Market Share by Manufacturer in 2017
Table North America Intravenous Immunoglobulin (IVIg) Revenue by Manufacturer (2016-2017)
Figure North America Intravenous Immunoglobulin (IVIg) Revenue Market Share by Manufacturer in 2016
Figure North America Intravenous Immunoglobulin (IVIg) Revenue Market Share by Manufacturer in 2017
Table North America Intravenous Immunoglobulin (IVIg) Sales by Type (2013-2018)
Table North America Intravenous Immunoglobulin (IVIg) Sales Share by Type (2013-2018)
Table North America Intravenous Immunoglobulin (IVIg) Revenue by Type (2013-2018)
Table North America Intravenous Immunoglobulin (IVIg) Revenue Share by Type (2013-2018)
Table North America Intravenous Immunoglobulin (IVIg) Sales by Application (2013-2018)
Table North America Intravenous Immunoglobulin (IVIg) Sales Share by Application (2013-2018)
Table North America Intravenous Immunoglobulin (IVIg) Revenue by Application (2013-2018)
Table North America Intravenous Immunoglobulin (IVIg) Revenue Share by Application (2013-2018)
Figure Europe Intravenous Immunoglobulin (IVIg) Revenue and Growth Rate (2013-2018)
Table Europe Intravenous Immunoglobulin (IVIg) Sales by Countries (2013-2018)
Table Europe Intravenous Immunoglobulin (IVIg) Sales Market Share by Countries (2013-2018)
Table Europe Intravenous Immunoglobulin (IVIg) Revenue by Countries (2013-2018)
Figure Europe Intravenous Immunoglobulin (IVIg) Revenue Market Share by Countries in 2016
Figure Europe Intravenous Immunoglobulin (IVIg) Revenue Market Share by Countries in 2017
Figure Germany Intravenous Immunoglobulin (IVIg) Sales and Growth Rate (2013-2018)
Figure UK Intravenous Immunoglobulin (IVIg) Sales and Growth Rate (2013-2018)
Figure France Intravenous Immunoglobulin (IVIg) Sales and Growth Rate (2013-2018)
Figure Russia Intravenous Immunoglobulin (IVIg) Sales and Growth Rate (2013-2018)
Figure Italy Intravenous Immunoglobulin (IVIg) Sales and Growth Rate (2013-2018)
Table Europe Intravenous Immunoglobulin (IVIg) Sales by Manufacturer (2016-2017)
Figure Europe Intravenous Immunoglobulin (IVIg) Sales Market Share by Manufacturer in 2016
Figure Europe Intravenous Immunoglobulin (IVIg) Sales Market Share by Manufacturer in 2017
Table Europe Intravenous Immunoglobulin (IVIg) Revenue by Manufacturer (2016-2017)
Figure Europe Intravenous Immunoglobulin (IVIg) Revenue Market Share by Manufacturer in 2016
Figure Europe Intravenous Immunoglobulin (IVIg) Revenue Market Share by Manufacturer in 2017
Table Europe Intravenous Immunoglobulin (IVIg) Sales by Type (2013-2018)
Table Europe Intravenous Immunoglobulin (IVIg) Sales Share by Type (2013-2018)
Table Europe Intravenous Immunoglobulin (IVIg) Revenue by Type (2013-2018)
Table Europe Intravenous Immunoglobulin (IVIg) Revenue Share by Type (2013-2018)
Table Europe Intravenous Immunoglobulin (IVIg) Sales by Application (2013-2018)
Table Europe Intravenous Immunoglobulin (IVIg) Sales Share by Application (2013-2018)
Table Europe Intravenous Immunoglobulin (IVIg) Revenue by Application (2013-2018)
Table Europe Intravenous Immunoglobulin (IVIg) Revenue Share by Application (2013-2018)
Figure Asia-Pacific Intravenous Immunoglobulin (IVIg) Revenue and Growth Rate (2013-2018)
Table Asia-Pacific Intravenous Immunoglobulin (IVIg) Sales by Countries (2013-2018)
Table Asia-Pacific Intravenous Immunoglobulin (IVIg) Sales Market Share by Countries (2013-2018)
Figure Asia-Pacific Intravenous Immunoglobulin (IVIg) Sales Market Share by Countries 2017
Table Asia-Pacific Intravenous Immunoglobulin (IVIg) Revenue by Countries (2013-2018)
Figure Asia-Pacific Intravenous Immunoglobulin (IVIg) Revenue Market Share by Countries 2017
Figure China Intravenous Immunoglobulin (IVIg) Sales and Growth Rate (2013-2018)
Figure Japan Intravenous Immunoglobulin (IVIg) Sales and Growth Rate (2013-2018)
Figure Korea Intravenous Immunoglobulin (IVIg) Sales and Growth Rate (2013-2018)
Figure India Intravenous Immunoglobulin (IVIg) Sales and Growth Rate (2013-2018)
Figure Southeast Asia Intravenous Immunoglobulin (IVIg) Sales and Growth Rate (2013-2018)
Table Asia-Pacific Intravenous Immunoglobulin (IVIg) Sales by Manufacturer (2016-2017)
Figure Asia-Pacific Intravenous Immunoglobulin (IVIg) Sales Market Share by Manufacturer in 2016
Figure Asia-Pacific Intravenous Immunoglobulin (IVIg) Sales Market Share by Manufacturer in 2017
Table Asia-Pacific Intravenous Immunoglobulin (IVIg) Revenue by Manufacturer (2016-2017)
Figure Asia-Pacific Intravenous Immunoglobulin (IVIg) Revenue Market Share by Manufacturer in 2016
Figure Asia-Pacific Intravenous Immunoglobulin (IVIg) Revenue Market Share by Manufacturer in 2017
Table Asia-Pacific Intravenous Immunoglobulin (IVIg) Sales by Type (2013-2018)
Table Asia-Pacific Intravenous Immunoglobulin (IVIg) Sales Share by Type (2013-2018)
Table Asia-Pacific Intravenous Immunoglobulin (IVIg) Revenue by Type (2013-2018)
Table Asia-Pacific Intravenous Immunoglobulin (IVIg) Revenue Share by Type (2013-2018)
Table Asia-Pacific Intravenous Immunoglobulin (IVIg) Sales by Application (2013-2018)
Table Asia-Pacific Intravenous Immunoglobulin (IVIg) Sales Share by Application (2013-2018)
Table Asia-Pacific Intravenous Immunoglobulin (IVIg) Revenue by Application (2013-2018)
Table Asia-Pacific Intravenous Immunoglobulin (IVIg) Revenue Share by Application (2013-2018)
Figure South America Intravenous Immunoglobulin (IVIg) Revenue and Growth Rate (2013-2018)
Table South America Intravenous Immunoglobulin (IVIg) Sales by Countries (2013-2018)
Table South America Intravenous Immunoglobulin (IVIg) Sales Market Share by Countries (2013-2018)
Figure South America Intravenous Immunoglobulin (IVIg) Sales Market Share by Countries in 2017
Table South America Intravenous Immunoglobulin (IVIg) Revenue by Countries (2013-2018)
Table South America Intravenous Immunoglobulin (IVIg) Revenue Market Share by Countries (2013-2018)
Figure South America Intravenous Immunoglobulin (IVIg) Revenue Market Share by Countries in 2017
Figure Brazil Intravenous Immunoglobulin (IVIg) Sales and Growth Rate (2013-2018)
Figure Argentina Intravenous Immunoglobulin (IVIg) Sales and Growth Rate (2013-2018)
Figure Colombia Intravenous Immunoglobulin (IVIg) Sales and Growth Rate (2013-2018)
Table South America Intravenous Immunoglobulin (IVIg) Sales by Manufacturer (2016-2017)
Figure South America Intravenous Immunoglobulin (IVIg) Sales Ma
  • Global Factor IX Deficiency Treatment Market 2018 by Manufacturers, Countries, Type and Application, Forecast to 2023
    Published: 11-Oct-2018        Price: US 3480 Onwards        Pages: 128
    Factor IX (or Christmas factor) is one of the serine proteases of the coagulation system; it belongs to peptidase family S1. Deficiency of this protein causes hemophilia B. Scope of the Report: This report studies the Factor IX Deficiency Treatment market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Factor IX Deficiency Treatm......
  • Global Factor VIII Deficiency Treatment Market 2018 by Manufacturers, Countries, Type and Application, Forecast to 2023
    Published: 11-Oct-2018        Price: US 3480 Onwards        Pages: 153
    Factor VIII is an essential blood-clotting protein, which is also known as an antihemophilic factor. In individuals, factor VIII is encoded by F8 gene. Defects in F8 gene lead to hemophilia A, a recessive X-linked coagulation disorder. Factor VIII is generated in liver sinusoidal cells and endothelial cells outside the liver across the body. This protein mixes in the bloodstream in an inactive form, and binds to another molecule called von Willebrand factor, until a damage to blood vessels occur......
  • Global Hemophilia Drugs Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023
    Published: 04-Oct-2018        Price: US 3480 Onwards        Pages: 129
    The hemophilia treatment drugs market is experiencing entry of a large number of new drugs in the market. Few of them have already arrived and other long lasting clotting factors and more promising drugs are on their way to get launched in this market. For instance, follow up data from phase I/II study of hemophilia medicine ‘Emicizumab' by Roche has demonstrated promising results regarding safety and prophylactic efficiency in people with severe hemophilia A. Another example is of ‘Eloctate' fo......
  • Global Heparin Sodium Market Insights, Forecast to 2025
    Published: 04-Oct-2018        Price: US 3900 Onwards        Pages: 117
    This report researches the worldwide Heparin Sodium market size (value, capacity, production and consumption) in key regions like North America, Europe, Asia Pacific (China, Japan) and other regions. This study categorizes the global Heparin Sodium breakdown data by manufacturers, region, type and application, also analyzes the market status, market share, growth rate, future trends, market drivers, opportunities and challenges, risks and entry barriers, sales channels, distributors and P......
  • Global Intravenous Immunoglobulin (IVIg) Market Insights, Forecast to 2025
    Published: 04-Oct-2018        Price: US 3900 Onwards        Pages: 112
    This report studies the global market size of Intravenous Immunoglobulin (IVIg) in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Intravenous Immunoglobulin (IVIg) in these regions. This research report categorizes the global Intravenous Immunoglobulin (IVIg) market by players/brands, region, type and application. This report also studies the global market status, competition landscape, market share, gr......
  • Global Intravenous Immunoglobulins Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023
    Published: 03-Oct-2018        Price: US 3480 Onwards        Pages: 115
    Immunoglobulin therapy is the use of a mixture of antibodies (immunoglobulins) to treat a number of health conditions. These conditions include primary immunodeficiency, idiopathic thrombocytopenic purpura, chronic inflammatory demyelinating polyneuropathy, Kawasaki disease, certain cases of HIV/AIDS and measles, Guillain-Barré syndrome, and in certain other infections when a more specific immunoglobulin is not available. Depending on the formulation it can be given by injection into muscle, a v......
  • Global Thrombus Partnering 2012 to 2018
    Published: 01-Oct-2018        Price: US 1995 Onwards        Pages: 100
    "Delivery of this report will take 1-3 days after purchase." Provides understanding and access to the thrombus (blood clot) partnering deals and agreements entered into by the worlds leading healthcare companies. The Global Thrombus Partnering Terms and Agreements since 2012 report provides understanding and access to partnering deals and agreements entered into by the world's leading healthcare companies. - Trends in partnering deals - Top de......
  • Global Hemophilia Partnering 2012 to 2018
    Published: 01-Oct-2018        Price: US 1995 Onwards        Pages: 150
    "Delivery of this report will take 1-3 days after purchase." Provides understanding and access to the hemophilia partnering deals and agreements entered into by the worlds leading healthcare companies. The Global Hemophilia Partnering Terms and Agreements since 2012 report provides understanding and access to partnering deals and agreements entered into by the world's leading healthcare companies. - Trends in partnering deals - Top deals by va......
  • Global Hematology Partnering 2012-2018: Deal trends, players and financials
    Published: 01-Oct-2018        Price: US 2995 Onwards        Pages: 600
    "Delivery of this report will take 1-3 days after purchase." The Global Hematology Partnering 2012-2018: Deal trends, players and financials report provides comprehensive understanding and unprecedented access to the hematology partnering deals and agreements entered into by the worlds leading healthcare companies Global Hematology Partnering 2012 to 2018 provides the full collection of Hematology disease deals signed between the world's pharmaceutical and biotechn......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs